Publicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (35)

2024

  1. Extended Prone Position and 90-Day Mortality in Mechanically Ventilated Patients With COVID-19

    Respiratory care, Vol. 69, Núm. 10, pp. 1255-1265

2023

  1. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

2022

  1. Postsurgical calcified left ventricular intramyocardial dissecting hematoma

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 55-56

  2. Real-life burden of hospitalisations due to COPD exacerbations in Spain

    ERJ Open Research, Vol. 8, Núm. 3

  3. Risk factors for 90-day mortality in critically ill ICU patients who undergo a tracheostomy. Frailty: A matter of great concern

    Acta Colombiana de Cuidado Intensivo, Vol. 22, Núm. 3, pp. 171-181

  4. Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry

    Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 9, pp. 2520-2528

2021

  1. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  2. COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)

    European Journal of Clinical Investigation, Vol. 51, Núm. 11

  3. Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart

    Clinical and Experimental Medicine, Vol. 21, Núm. 2, pp. 249-268

  4. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

    Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280

  5. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study

    Medicina Clinica, Vol. 156, Núm. 9, pp. 428-436

  6. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  7. Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: A subanalysis from the HOPE COVID-19 registry

    Emergency Medicine Journal, Vol. 38, Núm. 5, pp. 359-365

  8. Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases

    Archivos de Bronconeumologia, Vol. 57, pp. 13-20

  9. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data

    Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324

  10. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

    Frontiers in Medicine, Vol. 8

  11. The role of C-reactive protein in patient risk stratification and treatment

    European Cardiology Review , Vol. 16

2020

  1. Obstructive sleep Apnoea syndrome: Continuous positive airway pressure therapy for prevention of cardiovascular risk

    European Cardiology Review , Vol. 15

  2. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis

    Frontiers in Endocrinology, Vol. 11

  3. Type 2 Diabetes Mellitus, Glycated Hemoglobin Levels, and Cardiopulmonary Exercise Capacity in Patients With Ischemic Heart Disease

    Journal of cardiopulmonary rehabilitation and prevention, Vol. 40, Núm. 3, pp. 167-173